Table 3. Outcome data.

	ATG-F (n = 18)	Thymo (n = 17)	p = value
GFR [ml/min/1.73m2], median (range)
month 1	50.7 (29–99)	51.7 (26–86)	0.55
month 6	53.4 (29–119)	49.5 (23–117)	1.00
month 12	52.5 (29–96)	57.1 (39–125)	0.97
month 24	55.9 (24–128)	51.3 (22–132)	0.69
Creatinine [umol/l], median (range)
month 1	133 (77–225)	127 (87–274)	0.55
month 6	127 (66–211)	140.5 (68–300)	0.89
month 12	129.5 (77–211)	123.5 (64–187)	0.88
month 24	125 (59–252)	134.5 (61–287)	0.60
Delayed graft function, (n/n)%	4/17	6/17	0.71
Primary non function, (n/n)%	1/18	0/17	1.00
Prot/Crea [mg/mmol], median (range)
month 6	18.2 (6–129)	17.8 (5–346)	0.66
month 12	13.5 (0.06–96)	15.5 (0.06–161)	0.69
month 24	12.7 (3–57)	15.3 (1.4–667)	0.66
1-year patient survival	88.9%	82.4%	0.59
2-year patient survival	88.9%	82.4%
1-year graft survival	94.4%	100%	0.33
2-year graft survival	94.4%	100%